<?xml version="1.1" encoding="utf-8"?>
<rdf:RDF xmlns:OMEXlib="http://omex-library.org/"
   xmlns:bqbiol="http://biomodels.net/biology-qualifiers/"
   xmlns:bqmodel="http://biomodels.net/model-qualifiers/"
   xmlns:dc="http://purl.org/dc/terms/"
   xmlns:foaf="http://xmlns.com/foaf/0.1/"
   xmlns:local="http://omex-library.org/NewOmex.omex/NewModel.rdf#"
   xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#">
  <rdf:Description rdf:about="http://omex-library.org/BIOMD0000000341.omex">
    <bqmodel:isDescribedBy rdf:resource="local:00001"/>
    <ns1:keyword xmlns:ns1="http://prismstandard.org/namespaces/basic/2.0/">Biomodels</ns1:keyword>
    <ns2:description xmlns:ns2="http://purl.org/dc/elements/1.1/">&lt;body xmlns="http://www.w3.org/1999/xhtml"&gt;
  &lt;p&gt;
      This model is from the article:
      &lt;br/&gt;
  &lt;strong&gt; A model of beta-cell mass, insulin, and glucose kinetics: pathways to diabetes.
&lt;/strong&gt;
  &lt;br/&gt;
Topp B, Promislow K, deVries G, Miura RM, Finegood DT.
      &lt;em&gt;J Theor Biol.&lt;/em&gt;2000 Oct 21;206(4):605-19.
      &lt;a href="http://www.ncbi.nlm.nih.gov/pubmed/11013117"&gt;    11013117&lt;/a&gt;,
      &lt;br/&gt;
  &lt;strong&gt;Abstract:&lt;/strong&gt;
  &lt;br/&gt;
Diabetes is a disease of the glucose regulatory system that is associated with increased morbidity and early mortality. The primary variables of this system are beta-cell mass, plasma insulin concentrations, and plasma glucose concentrations. Existing mathematical models of glucose regulation incorporate only glucose and/or insulin dynamics. Here we develop a novel model of beta -cell mass, insulin, and glucose dynamics, which consists of a system of three nonlinear ordinary differential equations, where glucose and insulin dynamics are fast relative to beta-cell mass dynamics. For normal parameter values, the model has two stable fixed points (representing physiological and pathological steady states), separated on a slow manifold by a saddle point. Mild hyperglycemia leads to the growth of the beta -cell mass (negative feedback) while extreme hyperglycemia leads to the reduction of the beta-cell mass (positive feedback). The model predicts that there are three pathways in prolonged hyperglycemia: (1) the physiological fixed point can be shifted to a hyperglycemic level (regulated hyperglycemia), (2) the physiological and saddle points can be eliminated (bifurcation), and (3) progressive defects in glucose and/or insulin dynamics can drive glucose levels up at a rate faster than the adaptation of the beta -cell mass which can drive glucose levels down (dynamical hyperglycemia).   &lt;/p&gt;
&lt;/body&gt;</ns2:description>
    <ns3:title xmlns:ns3="http://purl.org/dc/elements/1.1/">A model of beta-cell mass, insulin, and glucose kinetics: pathways to diabetes</ns3:title>
  </rdf:Description>
  <rdf:Description rdf:about="local:00001">
    <ns4:identifier xmlns:ns4="http://purl.org/dc/elements/1.1/"
       rdf:resource="http://identifiers.org/doi/10.1006/jtbi.2000.2150"/>
    <ns5:label xmlns:ns5="http://www.w3.org/2000/01/rdf-schema#">BRIAN TOPP, KEITH PROMISLOW, GERDA DEVRIES, ROBERT M MIURA &amp; DIANE T FINEGOOD. A model of beta-cell mass, insulin, and glucose kinetics: pathways to diabetes. Journal of Theoretical Biology 206, 4 (2000).</ns5:label>
  </rdf:Description>
</rdf:RDF>

